Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately for further instructions.
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Thalidomide (severe)
Deferiprone (severe)
Sunitinib (severe)
Topotecan (moderate)
This medicine is used in the treatment of colorectal cancer. The colon and rectum are parts of the large intestine. Colorectal cancer occurs when tumors form in the lining of the large intestine.
This medicine is used in the treatment of non-small cell lung cancer. It is a type of lung cancer characterized by symptoms such as a persistent cough, shortness of breath, weight loss, coughing up blood, etc.
This medicine is used in the treatment of glioblastoma multiforme, an aggressive type of brain cancer characterized by symptoms such as a headache, drowsiness, nausea, blurred vision, seizures, changes in personality, etc.
This medicine is used in the treatment of renal cell carcinoma, which is the most common type of kidney cancer.
This medicine is used in the treatment of cervical cancer, a cancer of the cervix characterized by symptoms such as bleeding in between periods, foul-smelling white discharge, low back pain, lower abdominal pain, etc.
This medicine is used in the treatment of cancer of the ovaries.
This medicine is used in the treatment of fallopian tube cancer.
This medicine is used in the treatment of peritoneal cancer. It develops in a thin layer of tissue that lines the abdomen called the peritoneum.
Black or Tarry stools
Bleeding gums
Body aches or Pain
Burning, numbness, tingling in the arms and feet
Chest pain
Chills
Cloudy urine
Decreased urine output
Dilated neck veins
Fever
Irregular breathing
Seizures
Sore throat
Sweating
Unusual bleeding or bruising
Unusual tiredness and weakness
Dizziness
This medicine is not recommended for use in patients with a known allergy to Avastin Injection 400 mg 16 mL or any other active ingredients present along with this medicine.
This medicine is not recommended for use in patients with significant bleeding disorders since it may worsen the patient's condition.
This medicine is not recommended for use for at least 28 days prior to and 28 days after a surgical procedure or until the surgical wound is fully healed due to the increased risk of serious adverse effects.